Photo: Dr. Juan I. Imbaud during its presentation. 14th, November 2017 PROALT was nominated for the Innovation Award and presented its colorectal cancer diagnostic and therapeutic projects at the eHealth Venture Summit 2017 in November 14th. The competition took place as part of MEDICA HEALTH FORUM in Düsseldorf (Germany) from 13-16 November. The eHealth Venture [...]
Photo: Dr. Juan I. Imbaud. Poster session B47 26th, October 2017 PROALT attends AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. During the event, organized in Philadelphia (PA) from 26th to 30th October, Dr Juan Ignacio Imbaud, the company Director, exposed a poster that showed the latest results of [...]
22nd, June 2017 PROALT was present at BIO 2017 International Convention in San Diego CA (USA) from 19 to 22 June. The company exhibited all its business activities in a booth located within the Spanish pavilion, where several contacts with companies' representatives were celebrated, and also participated in the partnering area (business forum) to have [...]
3rd, October 2016 PROALT has attended BIOSPAIN 2016. This year's event has been held from 28th to 31st September 2016 in Bilbao (Spain). PROALT participated with a booth at the exhibition area of BioSpain. PROALT also met other attendees during the business partnering and presented its business project at the Investment Forum. [...]
10th, June 2016 PROALT has participated in BIO International Convention 2016. The event has been held in San Francisco (United States) from 6 to 9 June 2016 . The Spanish Pavillion was organized by ICEX (Spain Trade and Investment) and The Spanish Trade Commission in Chicago, and brought together other 52 companies and Spanish biotech [...]
10th, June 2016 PROALT has been selected by Enterprise Europe Network (EEN) as a successfully funded company and invited to present its ColoDetect project in the European Commission's booth #5977 at BIO International Convention trade fair. The event, hold in San Francisco (United States), took place on Wednesday 8 June 2016. PROALT presented the key [...]
1st, April 2016 ColoDetect project announces the launch of its website. ColoDetect is a project funded by the European Union through the H2020 SME Instrument Phase 2 and developed by Protein Alternatives (PROALT). The project started in October 2015 and will run for three years. Its objective is the development and commercialization of a blood-based [...]
October 1st, 2015 COLODETECT, a proposal submitted by the Spanish biotechnology company PROALT, has been selected to receive EU funding from H2020 SME Instrument. In total, the Commission received 580 project proposals from European SMEs by the first cut-off date of the so-called Horizon 2020’s SME Instrument Phase 2. PROALT is the only Spanish company [...]
18th, June 2015 PROALT has participated in BIO International Convention 2015. This year's event has been held from 15 to 18 June 2015 in Philadelphia (United States). The Spanish Pavillion was organized by ICEX (Spain Trade and Investment) and The Spanish Trade Commission in Chicago, and brought together other 52 companies and Spanish biotech institutions. [...]
May 6th, 2015 The 'Innovators' supplement of the 'El Mundo' newspaper, one of the most widely distributed journals in Spain, has interviewed Dr Juan Ignacio Imbaud, R&D Director of the biotech company Protein Alternatives (Madrid, Spain). The reason was the recent approval of the project named COLODETECT, which was presented by the company to the [...]
Copyright ©2020 Protein Alternatives SL. All rights reserved | Legal Notice & Privacy Policy
